Compound Q&A

Is Rifaximin (CAS: 80621-81-4) safe?

Answer

Rifaximin
Rifaximin (CAS: 80621-81-4) is generally considered safe when used as directed. It has a low risk of systemic toxicity and is well-tolerated in most patients. However, like all medications, it may cause side effects such as nausea, headache, or abdominal pain. Proper handling and adherence to medical guidelines are essential to ensure safety and effectiveness.

About

CAS No 80621-81-4
English Name Rifaximin
Molecular Formula C43H51N3O11
Molecular Weight 785.9 g/mol
SMILES CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
InChIKey NZCRJKRKKOLAOJ-XRCRFVBUSA-N
Last Updated: 2025-08-25 01:07

Related Q&A

Compound Q&A

What is Rifaximin (CAS: 80621-81-4)?

Rifaximin is an antibiotic medication with the CAS number 80621-81-4. It is a semisynthetic rifamyci...

Compound Q&A

What are the main uses of Rifaximin (CAS: 80621-81-4)?

Rifaximin (CAS: 80621-81-4) is mainly used to treat infections of the gastrointestinal tract, such a...

Compound Q&A

How should Rifaximin (CAS: 80621-81-4) be stored?

Rifaximin (CAS: 80621-81-4) should be stored in a cool, dry place away from direct light. It is typi...

Compound Q&A

What is 6-Methyl-7-oxabicyclo[4.1.0]heptan-2-one (CAS: 21889-89-4)?

6-Methyl-7-oxabicyclo[4.1.0]heptan-2-one is a cyclic ketone with a molecular for...

21889-89-46-Methyl-7-oxabicycl...
Compound Q&A

What is 4-[(6-Methyl-2-pyrazinyl)oxy]benzoic acid (CAS: 906353-00-2)?

4-[(6-Methyl-2-pyrazinyl)oxy]benzoic acid is a chemical compound with the CAS nu...

906353-00-24-[(6-Methyl-2-pyraz...
Compound Q&A

What is 2-(2-Pyridinyl)-1,3-propanediol (CAS: 49745-42-8)?

2-(2-Pyridinyl)-1,3-propanediol (CAS: 49745-42-8) is a colorless to slightly yel...

49745-42-82-(2-Pyridinyl)-1,3-...
Compound Q&A

What is 2-(6-Chloro-2-pyridinyl)-2-phenylacetonitrile (CAS: 24783-42-4)?

2-(6-Chloro-2-pyridinyl)-2-phenylacetonitrile is an organic compound with the CA...

24783-42-42-(6-Chloro-2-pyridi...